Stay updated on Soticlestat in Rare Epilepsies Clinical Trial
Sign up to get notified when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.

Latest updates to the Soticlestat in Rare Epilepsies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing Revision: v3.2.0, with no changes to the trial details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the notice about potential delays and updates due to a lapse in government funding and the NIH Clinical Center's operating status.SummaryDifference0.3%

- Check35 days agoChange DetectedThe ENDYMION 1 study (NCT03635073) has been terminated and closed by the sponsor due to negative results from related phase 3 trials, and this termination is noted on the Study Details page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe ENDYMION 1 study (NCT03635073) has been terminated and closed; supplementary data from TAK-935-18-001 is no longer necessary.SummaryDifference0.3%

- Check72 days agoChange DetectedMajor change: update to v3.2.0 and a prominent notice about funding-related accessibility and where to check operating status. Previous v3.1.0 was removed. If no significant changes were detected beyond this, the page now communicates funding-related status and directs users to official status sources.SummaryDifference3%

- Check79 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%

Stay in the know with updates to Soticlestat in Rare Epilepsies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.